Late coronary stent thrombosis

Area of Science:

• Cardiology
• Biomaterials Science

Background:

• Coronary stent thrombosis (ST) is a significant complication following percutaneous coronary intervention (PCI).
• ST is categorized as early (within one month) or late (after one month), both posing risks of acute myocardial infarction and sudden cardiac death.
• While early ST is associated with implantation factors and dual antiplatelet therapy, late ST (LST) is increasingly recognized, particularly after drug-eluting stent (DES) implantation.

Purpose of the Study:

• To differentiate the pathogenetic mechanisms of early and late stent thromboses.
• To explore the association between different types of DES and the risk of LST.
• To investigate the potential role of polymer-based tissue reactions in very late stent thrombosis (VLST).

Main Methods:

• Review of existing literature on coronary stent thrombosis.
• Analysis of pathogenetic mechanisms differentiating early, late, and very late stent thrombosis.
• Evaluation of the impact of stent type (bare metal vs. drug-eluting) and polymer composition on thrombosis risk.

Main Results:

• Early ST is primarily linked to PCI technique, lesion complexity, and dual antiplatelet therapy.
• Late ST (LST) is rare but severe, predominantly observed with DES implantation.
• Emerging evidence suggests VLST (occurring >1 year post-PCI) may be related to local tissue responses to stent polymers.

Conclusions:

• Understanding the distinct mechanisms of early and late ST is crucial for risk stratification and management.
• Newer generation DES with improved polymer formulations (tissue-friendly or bioabsorbable) hold promise for reducing LST risk.
• Further research into polymer-tissue interactions is warranted to mitigate VLST.